The relationship between loss-to-follow-up (LTFU) in HIV treatment and care programmes and psychosocial factors, including self-reported stigma, is important to understand. This prospective cohort study explored stigma and LTFU in treatment eligible adults who had yet not started antiretroviral therapy (ART).Psychosocial, clinical and demographic data were collected at a baseline interview. Self-reported stigma was measured with a multi-item scale. LTFU was defined as not attending clinic in the 90 days since last appointment or before death. Data was collected between January 2009 and January 2013 and analysed using Cox Regression.380 individuals were recruited (median time in study 3.35 years, total time at risk 1065.81 person-years). 203...
A significant proportion of those initiating antiretroviral treatment (ART) for HIV infection are lo...
Background: Timely initiation of antiretroviral treatment (ART) requires sustained engagement in HIV...
Depression affects over 40% of people with HIV (PHIV) in low- and middle-income countries, and over ...
The relationship between loss-to-follow-up (LTFU) in HIV treatment and care programmes and psychosoc...
The relationship between loss-to-follow-up (LTFU) in HIV treatment and care programmes and psychosoc...
Background: Attrition from HIV treatment and care programmes presents significant public health prob...
Abstract Background Timely initiation of antiretroviral treatment (ART) requires sustained engagemen...
The World Health Organisation (WHO) recommends antiretroviral treatment (ART) initiation at human im...
The aim of this study is to examine whether internalized AIDS stigma among HIV patients one year aft...
A critical component of an AIDS-free generation is to reduce HIV-related stigma. Previous research p...
The present study investigated the influence of HIV-related stigma, social support, and impact of HI...
Background: Stigma is a recognised problem for effective prevention, treatment and care of HIV/AIDS....
A significant proportion of those initiating antiretroviral treatment (ART) for HIV infection are lo...
The availability of antiretroviral medications has transformed living with HIV infection into a mana...
Abstract Background Stigma is a barrier to HIV prevention and treatment. There is a limited understa...
A significant proportion of those initiating antiretroviral treatment (ART) for HIV infection are lo...
Background: Timely initiation of antiretroviral treatment (ART) requires sustained engagement in HIV...
Depression affects over 40% of people with HIV (PHIV) in low- and middle-income countries, and over ...
The relationship between loss-to-follow-up (LTFU) in HIV treatment and care programmes and psychosoc...
The relationship between loss-to-follow-up (LTFU) in HIV treatment and care programmes and psychosoc...
Background: Attrition from HIV treatment and care programmes presents significant public health prob...
Abstract Background Timely initiation of antiretroviral treatment (ART) requires sustained engagemen...
The World Health Organisation (WHO) recommends antiretroviral treatment (ART) initiation at human im...
The aim of this study is to examine whether internalized AIDS stigma among HIV patients one year aft...
A critical component of an AIDS-free generation is to reduce HIV-related stigma. Previous research p...
The present study investigated the influence of HIV-related stigma, social support, and impact of HI...
Background: Stigma is a recognised problem for effective prevention, treatment and care of HIV/AIDS....
A significant proportion of those initiating antiretroviral treatment (ART) for HIV infection are lo...
The availability of antiretroviral medications has transformed living with HIV infection into a mana...
Abstract Background Stigma is a barrier to HIV prevention and treatment. There is a limited understa...
A significant proportion of those initiating antiretroviral treatment (ART) for HIV infection are lo...
Background: Timely initiation of antiretroviral treatment (ART) requires sustained engagement in HIV...
Depression affects over 40% of people with HIV (PHIV) in low- and middle-income countries, and over ...